IMMUNOTHERAPY OF CANCER. PRESENT STATUS AND FUTURE POTENTIAL = L'IMMUNOTHERAPIE DU CANCER. ETAT ACTUEL ET POSSIBILITES FUTURESMORTON DL.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 6; PP. 1647-1655; BIBL. 28 REF.Serial Issue

IMMUNOTHERAPY OF HUMAN LEUKEMIA = IMMUNOTHERAPIE DANS LA LEUCEMIE HUMAINEBAKER MA; TAUB RN.1972; MOUNT SINAI J. MED.; U.S.A.; DA. 1972; VOL. 39; NO 6; PP. 548-565; BIBL. 6P.Serial Issue

IMMUNOTHERAPY IN LEUKEMIA: EXPERIMENTAL AND CLINICAL APPROACHES = IMMUNOTHERAPIE DANS LA LEUCEMIE: TENTATIVES EXPERIMENTALES ET CLINIQUESMATHE G.1972; SER. HAEMATOL.; DANEM.; DA. 1972; VOL. 5; NO 5; PP. 66-86; BIBL. 4P.Serial Issue

Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen = Traitement de la leucémie murine par des anticorps monoclonaux dirigés contre un antigène de différenciation normalBADGER, C. C; BERNSTEIN, I. D.The Journal of experimental medicine. 1983, Vol 157, Num 3, pp 828-842, issn 0022-1007Article

Response of agranulocytosis to prolonged antithymocyte globulin therapyCHUDWIN, D. S; COWAN, M. J; GREENBERG, P. L et al.The Journal of pediatrics. 1983, Vol 103, Num 2, pp 223-227, issn 0022-3476Article

Les cures de désensibilisation = ImmunotherapyLEYNADIER, F.Gazette médicale de France (1969). 1989, Vol 96, Num 19, pp 61-64, issn 0016-5557Article

Current status and challenges of cytokine pharmacologyZIDEK, Z; ANZENBACHER, P; KMONICKOVA, E et al.British journal of pharmacology. 2009, Vol 157, Num 3, pp 342-361, issn 0007-1188, 20 p.Article

HORIZONS IN TUMOR IMMUNOLOGY = PERSPECTIVES DANS L'IMMUNOLOGIE DES TUMEURSMORTON DL.1973; SURGERY; U.S.A.; DA. 1973; VOL. 74; NO 1; PP. 69-79; BIBL. 1P.Serial Issue

IMMUNOLOGIC ASPECTS OF OSTEOSARCOMA AND THEIR APPLICATION TO THERAPY. A PRELIMINARY REPORT = ASPECTS IMMUNOLOGIQUES DE L'OSTEOSARCOME ET LEUR APPLICATION EN THERAPEUTIQUE. UNE PUBLICATION PRELIMINAIREMARSH B; FLYNN L; ENNEKING W et al.1972; J. BONE JOINT SURG., AMER. ED.; U.S.A.; DA. 1972; VOL. 54A; NO 7; PP. 1367-1397; BIBL. 1P.1/2Serial Issue

BIOLOGICAL EFFECTS OF CORYNEBACTERIUM PARVUM. III. AMPLIFICATION OF RESISTANCE AND IMPAIRMENT OF ACTIVE IMMUNITY TO MURINE TUMOURS = EFFETS BIOLOGIQUES DE CORYNEBACTERIUM PARVUM. III. AMPLIFICATION DE RESISTANCE ET ALTERATION DE L'IMMUNITE ACTIVE VIS-A-VIS DE TUMEURS MURINESSMITH SE; SCOTT MT.1972; BRIT. J. CANCER; G.B.; DA. 1972; VOL. 26; NO 5; PP. 361-367; BIBL. 20 REF.Serial Issue

New trends in immunosuppression and immunotherapySHUIPING JIANG; LOMBARDI, Giovanna.International immunopharmacology. 2006, Vol 6, Num 13-14, pp 1874-1878, issn 1567-5769, 5 p.Conference Paper

Pratique de l'immunothérapie sublinguale par une équipe allergologique en consultation hospitalière et libérale = Sublingual-swallowed immunotherapy as administered by allergists in outpatient and private practice settingsPRADALIER, A; LEGALLAIS, D; ANDRE, C et al.Revue française d'allergologie et d'immunologie clinique. 2003, Vol 43, Num 6, pp 408-412, issn 0335-7457, 5 p.Article

Immunotherapy concepts under investiaationKÜNDIG, T. M.Allergy (Copenhagen). 2011, Vol 66, pp 60-62, issn 0105-4538, 3 p., SUP95Conference Paper

Use of an Sm-p80-Based Therapeutic Vaccine to Kill Established Adult Schistosome Parasites in Chronically Infected BaboonsKARMAKAR, Souvik; WEIDONG ZHANG; CARTER, Darrick et al.The Journal of infectious diseases. 2014, Vol 209, Num 12, pp 1929-1940, issn 0022-1899, 12 p.Article

Immunothérapie passive et immunodépressionMOUTHON, Luc; BEREZNE, Alice; LARROCHE, Claire et al.Annales de l'Institut Pasteur. Actualités. 2001, Num 7, pp 47-68, issn 0924-4204Article

Guide de bonne pratique médicale en allergologie : hyposensibilisation spécifique parentérale = Practice guide line in allergology: Parenteral specific hyposensibilisationRevue française d'allergologie et d'immunologie clinique. 1990, Vol 30, Num 1, pp 41-43, issn 0335-7457Article

Serum aluminium in hyposensitized allergicsVIND JOELT, S; MALLING, H.-J; GERNER SVENDSEN, V et al.Allergy (Copenhagen). 1985, Vol 40, Num 7, pp 487-490, issn 0105-4538Article

Perspectives d'immunothérapie du syndrome d'immunodéficience acquise (SIDA) = Immunotherapy in the AIDSAIUTI, F; BONOMO, R; MEZZAROMA, I et al.Médecine et hygiène. 1984, Vol 42, Num 1563, pp 1550-1554, issn 0025-6749Article

Antithymocyte globulin treatment of severe aplastic anaemiaMILLER, W. J; BRANDA, R. F; FLYNN, P. J et al.British journal of haematology. 1983, Vol 55, Num 1, pp 17-25, issn 0007-1048Article

Adjunct Immunotherapies for TuberculosisUHLIN, Michael; ANDERSSON, Jan; ZUMLA, Alimuddin et al.The Journal of infectious diseases. 2012, Vol 205, issn 0022-1899, S325-S334, SUP2Article

Immunoglobulin therapyFINLAYSON, J. S; TANKERSLEY, D. L.Lancet (British edition). 1991, Vol 338, Num 8771, pp 893-894, issn 0140-6736Article

Evolution des techniques de l'immunothérapie spécifique dans les allergies immédiates = Evolution of specific immunotherapy technics in proximate allergiesDRY, J.Bulletin de l'Académie nationale de médecine. 1983, Vol 167, Num 7, pp 731-735, issn 0001-4079Article

L'immunothérapie des cancers en 1983 = Immunotherapy of cancer in 1983MATHE, G; MISSET, J.-L.Gazette médicale de France (1969). 1983, Vol 90, Num 38, pp 3921-3926, issn 0016-5557Article

INTERFERONS AS ANTITUMOR AGENTSKIRCHNER H.1982; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; ISSN 0171-5216; DEU; DA. 1982; VOL. 103; NO 1; PP. 1-6; BIBL. 25 REF.Article

L'immunothérapie passe la quatrième avec les CAR T-cells : IMMUNO-ONCOLOGIE: Le combat biotech contre le cancerSIMON, Mathieu; SMITH, Julianne; VERNET, Agnès et al.Biofutur (Puteaux). 2014, Vol 352, pp 44-47, issn 0294-3506, 4 p.Article